Ezintsha Clinical Research Center
Johannesburg, Gauteng, 2193, South Africa
NCT Number: NCT04431154
This study aims to test if small incentives promote linkage to care and 6-month viral suppression among individuals recently tested for HIV at selected sites within Johannesburg, South Africa. Individuals who obtain a reactive HIV test result will be randomized to receive either the standard of care (SOC) for linkage to care or to receive financial incentives for confirmatory testing, linkage to care and viral suppression.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Johannesburg, Gauteng, 2193, South Africa
This study is in collaboration with Ezintsha, a sub-division of Wits Reproductive Health and HIV Institute (WRHI) in South Africa. This study will leverage on the existing research infrastructure of Ezintsha, including, HIVSS testing through the STAR initiative (Self-Test Africa), as well as HIV positive persons identified through other Ezintsha research studies and at Eztinsha affiliated health clinics.
This study will use a randomized trial design to test the effectiveness of incentives to increase confirmatory testing, linkage to care and viral suppression. The aim of this study is to determine whether HIV-infected men and women are more likely to achieve or maintain HIV virologic suppression if offered financial incentives vs. no incentives (standard of care).
Individuals who report receiving a reactive HIVSS test result on the STAR programme, or a HIV reactive test in another research study or at a affiliated clinic, will be randomized into one of two groups: a) a control group that receives the standard of care (SOC) for linkage to care; and b) an intervention group that receives financial incentives for confirmatory testing, linkage to care, and viral suppression.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This arm will receive a HIV self-screen kit and additional incentives to promote adherence and linkage to care
Time frame: approximately 6 months
Viral suppression (plasma HIV RNA <400 copies/mL) at approximately 6 months after a positive HIV result
Time frame: approximately 4 weeks
Laboratory HIV confirmatory testing within approximately 4 weeks for participants with a positive HIV self-screening result.
Time frame: approximately 4 weeks
ART initiation within approximately 4 weeks after for those newly diagnosed with HIV
University of Pennsylvania
Other
Financial Incentives to Promote Linkage to Care and Viral Suppression Following HIV Testing: a Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03157258
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Milwaukee, Wisconsin, United States
View Trial DetailsNCT04192487
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Tustin, California, United States
View Trial DetailsNCT03729778
Acquired Immunodeficiency Syndrome, Bacterial Infections
Aurora, Colorado, United States
View Trial DetailsNCT03823209
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Cleveland, Ohio, United States
View Trial Details